Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Scienture Holdings (SCNX) EPS (Weighted Average and Diluted) (2016 - 2025)

Scienture Holdings' EPS (Weighted Average and Diluted) history spans 13 years, with the latest figure at -$1.76 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 118.37% to -$1.76 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.76, a 111.64% decrease, with the full-year FY2025 number at -$2.7, down 208.87% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$1.76 in Q4 2025 for Scienture Holdings, down from -$0.19 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for SCNX hit a ceiling of $16.77 in Q1 2024 and a floor of -$18.51 in Q4 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.56 across 5 years, with a median of -$0.7 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 1555.56% in 2022 and later skyrocketed 1760.4% in 2024.
  • Tracing SCNX's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.09 in 2021, then plummeted by 1555.56% to -$1.49 in 2022, then crashed by 1142.28% to -$18.51 in 2023, then soared by 151.76% to $9.58 in 2024, then crashed by 118.37% to -$1.76 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for SCNX at -$1.76 in Q4 2025, -$0.19 in Q3 2025, and -$0.48 in Q2 2025.